Imatinib mesylate is a tyrosine kinase inhibitor used in the treatment of cancers including chronic myeloid leukemia. In their study, however, Kerkelä et al. report that this drug can be ...
Expert Rev Anticancer Ther. 2009;9(6):839-849. BAY43-9006 (Sorafenib) Small-molecule inhibitor BRAF, EGFR, c-kit, PDGFR, VEGFR-2 and 3 Phase II-III (in combination with chemotherapy) TKI258 (CHIR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback